Structure Database (LMSD)

LMSD: Structure-based search results

LM_IDCommon NameSystematic NameFormulaMassMain ClassSub Class
LMFA0401000510-F4-NeuroP(4Z,7Z,11E)-12-(3,5-dihydroxy-2-((Z)-
pent-2-en-1-yl)cyclopentyl)-10-
hydroxydodeca-4,7,11-trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010043ent-10-F4t-NeuroP(R,4Z,7Z,11E)-12-((1R,2S,3S,5R)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010044ent-13-epi-10-F4c-NeuroP(R,4Z,7Z,11E)-12-((1R,2R,3S,5R)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010045ent-13-epi-10-F4t-NeuroP(R,4Z,7Z,11E)-12-((1S,2S,3S,5R)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010046ent-10-F4c-NeuroP(R,4Z,7Z,11E)-12-((1S,2R,3S,5R)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA0401004710-epi-10-F4c-NeuroP(R,4Z,7Z,11E)-12-((1R,2S,3R,5S)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA0401004810,13-diepi-10-F4t-NeuroP(R,4Z,7Z,11E)-12-((1R,2R,3R,5S)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA0401004910,13-diepi-10-F4c-NeuroP(R,4Z,7Z,11E)-12-((1S,2S,3R,5S)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA0401005010-epi-10-F4t-NeuroP(R,4Z,7Z,11E)-12-((1S,2R,3R,5S)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010051ent-10-epi-4-Ft-NeuroP(S,4Z,7Z,11E)-12-((1R,2S,3S,5R)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010052ent-10,13-diepi-4-Fc-NeuroP(S,4Z,7Z,11E)-12-((1R,2R,3S,5R)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010053ent-10,13-diepi-4-Ft-NeuroP(S,4Z,7Z,11E)-12-((1S,2S,3S,5R)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA04010054ent-10-epi-4-Fc-NeuroP(S,4Z,7Z,11E)-12-((1S,2R,3S,5R)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA0401005510-F4c-NeuroP(S,4Z,7Z,11E)-12-((1R,2S,3R,5S)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA0401005613-epi-10-F4t-NeuroP(S,4Z,7Z,11E)-12-((1R,2R,3R,5S)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA0401005713-epi-10-F4c-NeuroP(S,4Z,7Z,11E)-12-((1S,2S,3R,5S)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]
LMFA0401005810-F4t-NeuroP(S,4Z,7Z,11E)-12-((1S,2R,3R,5S)-3,5-
dihydroxy-2-((Z)-pent-2-en-1-yl)
cyclopentyl)-10-hydroxydodeca-4,7,11-
trienoic acid
C22H34O5378.2406Docosanoids [FA04]Neuroprostanes [FA0401]